Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Payables (2021 - 2026)

Biohaven has reported Payables over the past 6 years, most recently at $10.4 million for Q1 2026.

  • Quarterly results put Payables at $10.4 million for Q1 2026, down 45.55% from a year ago — trailing twelve months through Mar 2026 was $10.4 million (down 45.55% YoY), and the annual figure for FY2025 was $11.6 million, down 35.42%.
  • Payables reached $10.4 million in Q1 2026 per BHVN's latest filing, down from $11.6 million in the prior quarter.
  • Across five years, Payables topped out at $36.4 million in Q1 2024 and bottomed at $4.7 million in Q3 2022.
  • Median Payables over the past 5 years was $15.6 million (2023), compared with a mean of $15.8 million.
  • The largest annual shift saw Payables surged 151.69% in 2024 before it crashed 47.39% in 2025.
  • Over 5 years, Payables stood at $10.7 million in 2022, then surged by 45.54% to $15.6 million in 2023, then rose by 15.74% to $18.0 million in 2024, then crashed by 35.42% to $11.6 million in 2025, then dropped by 10.49% to $10.4 million in 2026.
  • Business Quant data shows Payables for BHVN at $10.4 million in Q1 2026, $11.6 million in Q4 2025, and $17.5 million in Q3 2025.